Biotechnology medicine manipulates the genetic material of living organisms to produce pharmaceuticals, which in many instances are designed to combat diseases once considered...
Keep Reading →
July 25 - News
AbbVie Inc (NYSE:ABBV) will release its quarterly report on Friday, and with its stock having jumped considerably since it started trading as a separate entity, investors are ...
Keep Reading →
July 24 - News
The first half of 2013 has seen remarkable growth in the biotech sector, with the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB) up >40% YTD. The industry continues to...
Keep Reading →
July 24 - News
For nearly two decades, investment pro Ken Fisher's stock picks have outperformed the overall market.
Keep Reading →
July 23 - News
Today, let's look at Fisher Asset Management, founded in 1979 by Ken Fisher.
Keep Reading →
July 23 - Hedge Funds
According to multiple reports , Harvard researchers Timothy Henrich and Daniel Kuritzkes have recently noted a surprising side-effect to cancer treatments performed on two separate...
Keep Reading →
July 22 - News
You may or may not have heard, but it's earnings season again.
Keep Reading →
July 22 - News
The biotech industry is a cutthroat one, with companies constantly racing to get new treatments approved by the FDA ahead of their rivals.
Keep Reading →
July 22 - News
The "people familiar with the matter" are out in full force spouting off about who's bidding for Onyx Pharmaceuticals, Inc.
Keep Reading →
July 19 - News
The upcoming all-oral hepatitis C treatments earned well-deserved attention for some staggering cure rates, particularly in patient groups who haven’t responded well to the ...
Keep Reading →
July 11 - News
It’s been a healthy year-to-date for the biotech sector, with the space logging huge gains above and beyond those of the broad based market.
Keep Reading →
July 10 - News
Hepatitis C, caused by the hepatitis C virus (HCV), is an infectious disease affecting the liver.
Keep Reading →
July 10 - News
We as a country have a come a long way over the past two decades with regard to treating HIV and reducing the number of AIDS diagnoses.
Keep Reading →
July 8 - News
For the second day in a row, the hot topic in the market is the bidding war for Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX). After rejecting Amgen, Inc.
Keep Reading →
July 3 - News
Recently, Amgen, Inc. (NASDAQ:AMGN) made a surprisingly low offer to acquire the pharmaceutical company Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX).
Keep Reading →
July 3 - News
AbbVie Inc (NYSE:ABBV) has risen more than 20% since it hit the market earlier this year. In fact, it has managed to beat the S&P 500 by nearly 10%.
Keep Reading →
July 1 - News
Stock price movements reflect investors' opinions about a company's worth; upward moves attracts investor interest because they indicates good performance.
Keep Reading →
July 1 - News
To prove my point, I looked at the multi-year chart and picked out some of the peaks.
Keep Reading →
July 1 - News
Idenix Pharmaceuticals Inc (NASDAQ:IDIX) just can't catch a break.
Keep Reading →
June 28 - News
Biotech companies sometimes get lucky, launching a drug into a new indication where there's no competition, but more often than not the biotech companies have to battle it out...
Keep Reading →
June 27 - News
Global equity markets have been rocked recently as fears of rising interest rates and tightening monetary possible make their way into the minds of the street.
Keep Reading →
June 26 - News
Dividend stocks are hard to come by in the biotech space.
Keep Reading →
June 26 - News
Investing in biotech companies can be risky; developing new drugs is a long, expensive, and uncertain process, and there is always considerable regulatory risk in the industry...
Keep Reading →
June 26 - News
For investors viewing AbbVie Inc (NYSE:ABBV) as a value play since its spin-off from Abbott Laboratories (NYSE:ABT), it is time to think again.
Keep Reading →
June 26 - News
Earnings Per Share (EPS) growth is one measure of a company's profitability. Since it is often the most commonly discussed performance metric, it tends to drive share prices.
Keep Reading →
June 25 - News
Hepatitis-C is a contagious virus that attacks the liver and can be found in acute or chronic forms.
Keep Reading →
June 24 - News
Gilead Sciences, Inc. (NASDAQ:GILD) has been one of the most prolific investments in the healthcare sector.
Keep Reading →
June 18 - News
Amgen, Inc. (NASDAQ:AMGN) is the world’s largest independent biotechnology company.
Keep Reading →
June 18 - News
The S&P 500 fell nearly 10% in June 2008, and investors began to brace for an eventual market crash later in the year.
Keep Reading →
June 17 - Stock Analysis
According to the World Health Organization, there are 34 million HIV-positive individuals in the world today, and the virus has claimed the lives of 25 million people since the...
Keep Reading →
June 17 - News
This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on.
Keep Reading →
June 13 - News
Our job here is to examine companies through an investing perspective.
Keep Reading →
June 12 - News
Many stocks encountered turbulence this week, but few were blown about like several biotech stocks.
Keep Reading →
June 10 - News
It is interesting to watch a bio company change tactics and go into an area it hasn't explored before. This, to me, is like watching a child suddenly grow up.
Keep Reading →
June 6 - News
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
Keep Reading →
June 5 - News
You have plenty of choices of where to invest your portfolio.
Keep Reading →
May 31 - News
Gilead Sciences, Inc. (NASDAQ:GILD) was in 63 hedge funds' portfolio at the end of March. GILD shareholders have witnessed an increase in hedge fund sentiment of late.
Keep Reading →
May 30 - News
Some stocks seem to have all the luck, offering the best of both worlds.
Keep Reading →
May 30 - News
After a 12-week run of seeing its share price rise for the week, Johnson & Johnson (NYSE:JNJ) stock fell last week.
Keep Reading →
May 29 - News
At the annual ASCO meeting in Chicago, thousands of health-care researchers and professionals unite to advance cancer treatment.
Keep Reading →
May 28 - News
You want to invest in biotech. You hear about all the monstrous pops and mini-fortunes that are built overnight.
Keep Reading →
May 28 - News
I have jokingly referred to Amgen, Inc. (NASDAQ:AMGN) in the past as a "senior citizen" of biotech. The company was founded 33 years ago, making Amgen, Inc.
Keep Reading →
May 24 - News
To the average investor, there are a multitude of indicators market participants can use to watch stocks.
Keep Reading →
May 23 - News
Johnson & Johnson (NYSE:JNJ)'s hepatitis C drug, simeprevir, recently received Priority Review status from the FDA.
Keep Reading →
May 22 - News
As I noted 11 weeks ago, cancer statistics are both staggering and disappointing.
Keep Reading →
May 20 - News
There's one drawback to having the stock market indexes hit record highs yet again: It makes finding truly horrendous health-care stocks for our weekly series much more challenging...
Keep Reading →
May 18 - News
Biotech investors rejoice. The ASCO abstracts are here.
Keep Reading →
May 16 - News
Gilead Sciences, Inc. (NASDAQ:GILD) reported a relatively rare earnings miss in the first quarter on May 2.
Keep Reading →
May 14 - News
The Centers for Disease Control and Prevention would put heart disease at the top of the list, since it's the leading cause of death in the nation.
Keep Reading →
May 14 - News
